In a review of more than 2,000 people with confirmed Ebola cases in the Democratic Republic of Congo, researchers found case fatality was 27% among Ervebo patients and 56% among unvaccinated patients. The findings were published Feb. 7 in The Lancet Infectious Diseases.
The study is the first to research the retrospective efficacy of the Ebola vaccine, the researchers said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.